Chemopreventive effects of curcumin on chemically induced mouse skin carcinogenesis in BK5.insulin-like growth factor-1 transgenic mice

[1]  Jen-kun Lin,et al.  Cycle arrest and apoptosis in MDA-MB-231/Her2 cells induced by curcumin. , 2012, European journal of pharmacology.

[2]  A. Srivastava,et al.  Attenuation of endothelin-1-induced PKB and ERK1/2 signaling, as well as Egr-1 expression, by curcumin in A-10 vascular smooth muscle cells. , 2012, Canadian journal of physiology and pharmacology.

[3]  Yan Li,et al.  Curcumin reverses cis-platin resistance and promotes human lung adenocarcinoma A549/DDP cell apoptosis through HIF-1α and caspase-3 mechanisms. , 2012, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[4]  Chih-Hsin Tang,et al.  Curcumin induces cell apoptosis in human chondrosarcoma through extrinsic death receptor pathway. , 2012, International immunopharmacology.

[5]  F. Bagnoli,et al.  Interaction between cyclooxygenase-2 and insulin-like growth factor in breast cancer: A new field for prevention and treatment. , 2012, Oncology letters.

[6]  M. Pollak.  The insulin and insulin-like growth factor receptor family in neoplasia: an update , 2012, Nature Reviews Cancer.

[7]  Chih-Pin Chuu,et al.  Combined Treatment of Curcumin and Small Molecule Inhibitors Suppresses Proliferation of A549 and H1299 Human Non‐Small‐Cell Lung Cancer Cells , 2012, Phytotherapy research : PTR.

[8]  J. Zidan,et al.  Curcuma as a functional food in the control of cancer and inflammation , 2011, Current opinion in clinical nutrition and metabolic care.

[9]  Claire Lugnier,et al.  Anti-proliferative effect of curcumin on melanoma cells is mediated by PDE1A inhibition that regulates the epigenetic integrator UHRF1. , 2011, Molecular nutrition & food research.

[10]  S. Bhattacharyya,et al.  Curcumin Enhances the Efficacy of Chemotherapy by Tailoring p65NFκB-p300 Cross-talk in Favor of p53-p300 in Breast Cancer* , 2011, The Journal of Biological Chemistry.

[11]  G. Stoica,et al.  Curcumin induces apoptosis in a murine mammary gland adenocarcinoma cell line through the mitochondrial pathway. , 2011, European journal of pharmacology.

[12]  J. Zeng,et al.  Formononetin Induces Cell Cycle Arrest of Human Breast Cancer Cells via IGF1/PI3K/Akt Pathways In Vitro and In Vivo , 2011, Hormone and Metabolic Research.

[13]  N. Yaegashi,et al.  Curcumin disrupts uterine leiomyosarcoma cells through AKT-mTOR pathway inhibition. , 2011, Gynecologic oncology.

[14]  M. McArthur,et al.  Genetic Reduction of Insulin-like Growth Factor-1 Mimics the Anticancer Effects of Calorie Restriction on Cyclooxygenase-2–Driven Pancreatic Neoplasia , 2011, Cancer Prevention Research.

[15]  T. Jap,et al.  Effects of long-acting release octreotide on glucose homeostasis in acromegaly patients after trans-sphenoidal surgery. , 2011, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[16]  F. Sarkar,et al.  Difluorinated-Curcumin (CDF): A Novel Curcumin Analog is a Potent Inhibitor of Colon Cancer Stem-Like Cells , 2011, Pharmaceutical Research.

[17]  Hongyu Zhou,et al.  The targets of curcumin. , 2011, Current drug targets.

[18]  E. Grande,et al.  Multiple roles and therapeutic implications of Akt signaling in cancer , 2009, OncoTargets and therapy.

[19]  N. Webster,et al.  Curcumin disrupts the Mammalian target of rapamycin-raptor complex. , 2009, Cancer research.

[20]  A. Kong,et al.  Curcumin inhibits Akt/mammalian target of rapamycin signaling through protein phosphatase-dependent mechanism , 2008, Molecular Cancer Therapeutics.

[21]  A. Rishi,et al.  Curcumin enhances the effects of 5‐fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF‐1R , 2008, International journal of cancer.

[22]  G. Thomas,et al.  mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. , 2007, Trends in molecular medicine.

[23]  Qiujuan Li,et al.  The potentiation of curcumin on insulin-like growth factor-1 action in MCF-7 human breast carcinoma cells. , 2007, Life sciences.

[24]  Shile Huang,et al.  Curcumin inhibits the mammalian target of rapamycin‐mediated signaling pathways in cancer cells , 2006, International journal of cancer.

[25]  Xiaoping Yang,et al.  Curcumin Inhibits Platelet-Derived Growth Factor–Stimulated Vascular Smooth Muscle Cell Function and Injury-Induced Neointima Formation , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[26]  Ricky A. Sharma,et al.  Curcumin: the story so far. , 2005, European journal of cancer.

[27]  Matthias Egger,et al.  Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis , 2004, The Lancet.

[28]  T. Libermann,et al.  Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors. , 2004, Cancer cell.

[29]  方福德.  构成性表达（constitutive expression） , 2003 .

[30]  S. Pal,et al.  Curcumin induces apoptosis in human breast cancer cells through p53‐dependent Bax induction , 2002, FEBS letters.

[31]  Y. Kido,et al.  Distinct and overlapping functions of insulin and IGF-I receptors. , 2001, Endocrine reviews.

[32]  R. Buttyan,et al.  Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo , 2001, The Prostate.

[33]  J. Jorcano,et al.  Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion. , 2000, Cancer research.

[34]  E. Wilker,et al.  Enhancement of susceptibility to diverse skin tumor promoters by activation of the insulin‐like growth factor‐1 receptor in the epidermis of transgenic mice , 1999, Molecular carcinogenesis.

[35]  V. Steele,et al.  Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. , 1999, Cancer research.

[36]  D. Bol,et al.  Altered expression of insulin‐like growth factor I and its receptor during multistage carcinogenesis in mouse skin , 1996, Molecular carcinogenesis.

[37]  T. Slaga,et al.  In vivo behavior of murine epidermal cell lines derived from initiated and noninitiated skin. , 1988, Cancer research.

[38]  S. Shishodia,et al.  Modulation of transcription factors by curcumin. , 2007, Advances in experimental medicine and biology.

[39]  A. Katz,et al.  Therapeutic potential of curcumin in human prostate cancer. II. Curcumin inhibits tyrosine kinase activity of epidermal growth factor receptor and depletes the protein. , 2000, Molecular urology.